focus -WSS

focus

author：comprehensive 2025-09-06 03:40:11 - browse：448

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Brain technologies pose threats that are all too real, experts warn

knowledge

WSS

Has Bernie Sanders reached the limit of his pharma bullying effort?

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Lawmakers grill UnitedHealth CEO on Change cyberattack

Oak Street deal isn't the answer to health care's woes

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

WuXi Biologics execs register to lobby as Congress comes for the company

hotspot

focus

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

United colonoscopy coverage change 'may cost lives,' doctors say

GSK’s asthma push continues as drug succeeds in Phase 3 trials

How one medical school became remarkably diverse

As H5N1 spreads in cows, experts warn against drinking raw milk

How one medical school became remarkably diverse

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Duchenne breakthrough therapy leaves behind pioneering families

Class action alleges UnitedHealth concealed DOJ probe

hotspot

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Lilly’s weekly insulin works as well as daily products, new studies show

Novo Nordisk testing Wegovy against alcohol

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Deliver public health messages at the right time

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

knowledge

entertainment

knowledge

leisure time